 |

| November 10, 2008 Issue |
Volume 70, Number 45 |
Lead Stories for this Issue
As Democrats Eye Drug Prices, Rep. Waxman Eyes The Commerce CommitteeSupreme Court Ruling In Wyeth v. Levine: What’s The Liability For FDA?The REMS Report Card: FDA Using New Tools For One-Third Of New Drugs In First Six Months
Go to this Issue >>
|
| November 3, 2008 Issue |
Volume 70, Number 44 |
Lead Stories for this Issue
Economic Forecast For Pharma: Winter Advisory AheadDrug Industry Braces For Supreme Court Ruling In Wyeth Pre-emption Case Express Scripts Tackles The Art And Science Of Consumer Decision-Making
Go to this Issue >>
|
| October 27, 2008 Issue |
Volume 70, Number 43 |
Lead Stories for this Issue
WellPoint Seeks More Quality Of Life, Cost Data In Formulary Submissions No Sales Model Left Behind: Novartis Joins Firms In Changing Market Focus NIH Consensus Panel: Long-Term Trials Needed To Better Manage Hepatitis B
Go to this Issue >>
|
|
 |
|
 |